Literature DB >> 7680954

Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

R J Scheper1, H J Broxterman, G L Scheffer, P Kaaijk, W S Dalton, T H van Heijningen, C K van Kalken, M L Slovak, E G de Vries, P van der Valk.   

Abstract

A M(r) 110,000 protein (p110) is overexpressed in P-glycoprotein-negative multidrug-resistant tumor cell lines of different histogenetic origins. These cell lines show an ATP-dependent drug accumulation defect, suggesting the presence of drug transporter molecules different from P-glycoprotein. Immunohistochemical staining with a p110-specific monoclonal antibody (LRP-56) showed that, like P-glycoprotein, the molecule has a high expression in normal epithelial cells and tissues chronically exposed to xenobiotics and potentially toxic agents, such as bronchial cells, cells lining the intestines, and kidney tubules. Staining of LRP-56 is primarily cytoplasmic, in a coarsely granular fashion, indicating that it reacts with a molecule closely associated with vesicular/lysosomal structures. Involvement of p110 in the energy-dependent drug transport process present in the cell lines is unknown.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680954

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  90 in total

1.  Expression of lung resistance protein in patients with gastric carcinoma and its clinical significance.

Authors:  Zhong-Min Liu; Nan-Hai Shou; Xi-Hong Jiang
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.

Authors:  P Duesberg; R Stindl; R Hehlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 3.  Promising approaches in acute leukemia.

Authors:  J Cortes; H M Kantarjian
Journal:  Invest New Drugs       Date:  2000-02       Impact factor: 3.850

4.  Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.

Authors:  Alyssa L Margiotta; Lisa J Bain; Charles D Rice
Journal:  Anat Rec (Hoboken)       Date:  2017-07-20       Impact factor: 2.064

5.  Intracellular distribution of anthracyclines in drug resistant cells.

Authors:  G Arancia; A Calcabrini; S Meschini; A Molinari
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

6.  Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

Authors:  M A Izquierdo; G L Scheffer; A B Schroeijers; M C de Jong; R J Scheper
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

7.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.

Authors:  M A Izquierdo; G L Scheffer; M J Flens; G Giaccone; H J Broxterman; C J Meijer; P van der Valk; R J Scheper
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

8.  Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

Authors:  M Kourti; N Vavatsi; N Gombakis; V Sidi; G Tzimagiorgis; T Papageorgiou; D Koliouskas; F Athanassiadou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer.

Authors:  J-J Yeh; N-Y Hsu; W-H Hsu; C-H Tsai; C-C Lin; J-A Liang
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

10.  16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1.

Authors:  Carsten Ehrhardt; Carsten Kneuer; Michael Laue; Ulrich Friedrich Schaefer; Kwang-Jin Kim; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.